Myelodysplastic SyndromesBone MarrowBone Marrow CellsBone Marrow TransplantationMyeloid CellsAnemia, RefractoryAnemia, Refractory, with Excess of BlastsBone and BonesSyndromeLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, ChronicBone Marrow DiseasesLeukemia, MyeloidHematopoietic Stem CellsBone Marrow ExaminationChromosomes, Human, Pair 5Anemia, SideroblasticAzacitidineAnemia, AplasticBone RemodelingBone Marrow NeoplasmsHematopoiesisLeukemiaPancytopeniaKaryotypingMyeloproliferative DisordersChromosome AberrationsTransplantation, HomologousPreleukemiaMonosomyThalidomideCell DifferentiationAcute DiseaseHematopoietic Stem Cell TransplantationPrognosisAntigens, CD34Bone DensityFlow CytometryMyelodysplastic-Myeloproliferative DiseasesGranulocyte Precursor CellsChromosomes, Human, Pair 7GranulocytesTreatment OutcomeCytogenetic AnalysisColony-Forming Units AssayMice, Inbred C57BLBone ResorptionGranulocyte Colony-Stimulating FactorChromosome DeletionBone Marrow PurgingWhole-Body IrradiationTransplantation, AutologousCells, CulturedGraft vs Host DiseaseMyeloid Progenitor CellsBlood Cell CountImmunophenotypingTransplantation ConditioningErythropoietinNeoplasms, Second PrimaryRemission InductionSurvival AnalysisCytogeneticsBone NeoplasmsMegakaryocytesTrisomyPrimary MyelofibrosisCytarabineAntimetabolites, AntineoplasticHematologic DiseasesErythrocyte TransfusionIron OverloadErythroid Precursor CellsThrombocytopeniaBlast CrisisErythropoiesisBone DevelopmentTime FactorsBusulfanBlood TransfusionHematologic AgentsAntineoplastic AgentsBone DiseasesSurvival RateGranulocyte-Macrophage Colony-Stimulating FactorAntigens, CDStromal CellsMutationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsIn Situ Hybridization, FluorescenceCell LineageRetrospective StudiesErythroblastsChelation TherapyDisease ProgressionLeukocyte CountRecurrenceAnemiaCyclophosphamide